12/14/2012 - 12:55pm

The Food and Drug Administration has approved a new leukemia drug made by Ariad Pharmaceuticals, the agency said.

12/12/2012 - 3:54pm

The Food and Drug Administration has accepted a regulatory approval application from Takeda and Lundbeck for an experimental drug to treat depression, the companies said Wednesday.

12/12/2012 - 3:09pm

GlaxoSmithKline is sponsoring a national campaign to investigate ways to build healthier communities in the United States and has made its latest stop, in St. Louis, the company said Wednesday.

12/12/2012 - 2:09pm

A subsidiary of Johnson & Johnson is seeking regulatory approval for a new Type 2 diabetes drug.

12/12/2012 - 1:48pm

Drug maker ViroPharma has launched an education campaign focused on a rare, debilitating and life-threatening genetic disorder.

12/12/2012 - 12:23pm

Swiss skin drug maker Galderma Pharma will acquire another Swiss drug maker also focused on treatments for skin conditions, Galderma said.

12/12/2012 - 12:13pm

Xenon Pharmaceuticals is licensing an experimental pain drug to Teva Pharmaceutical Industries in a deal worth up to $376 million, the companies said.

12/11/2012 - 2:04pm

Biotech and vaccines company Nuron Biotech has bought rights from Pfizer for a vaccine to prevent infection by a bacteria that is a major cause of infectious disease around the world.

12/11/2012 - 1:33pm

The New York Department of Health on Monday announced that reported cases of influenza are increasing throughout New York, and flu activity in the state is now considered to be widespread, with laboratory-confirmed cases in more than half the regions.